Table 1.
Data of the hepatitis C virus-positive kidney transplant recipients
| Sex | Age years | Blood group | Period since transplantation date (years) | Transplantation place | Donor | Cause of renal failure | HCV viral load copies/ml |
|---|---|---|---|---|---|---|---|
| Male | 47 | O+ | 1.6 | KSA | Live | Glomerulonephritis | 13,513 |
| Female | 23 | O+ | 6.6 | Iran | Live | SLE | 13,601 |
| Female | 54 | B+ | 1.8 | KSA | Live | Glomerulonephritis | 13,945 |
| Female | 34 | B+ | 3.9 | KSA | Live | Unknown | 14,021 |
| Female | 55 | O+ | 4.3 | Egypt | Live | Diabetic nephropathy | 14,233 |
| Male | 69 | O− | 7.7 | The Philippines | Live | Unknown | 15,123 |
| Female | 48 | O+ | 2.3 | Pakistan | Live | Glomerulonephritis | 15,700 |
| Female | 32 | O+ | 8.7 | The Philippines | Live | Renal stone | 15,700 |
| Male | 43 | A+ | 15 | KSA | Live | Hypertension | 18,910 |
| Male | 30 | O+ | 4.7 | KSA | Cadaver | Alport syndrome | 45,990 |
| Male | 43 | O+ | 6.9 | Pakistan | Live | Unknown | 78,553 |
| Female | 42 | O+ | 7.2 | Egypt | Live | Glomerulonephritis | 78,910 |
| Male | 35 | O+ | 3.8 | Pakistan | Live | Hypertension | 79,000 |
| Female | 36 | AB+ | 11 | KSA | Live | Unknown | 297,128 |
| Female | 53 | AB+ | 5.7 | KSA | Cadaver | Hypertension | 314,023 |
| Female | 52 | O+ | 7.5 | KSA | Live | Chronic pyelonephritis | 447,232 |
| Male | 39 | O+ | 1.6 | The Philippines | Live | Diabetic nephropathy | 1,223,049 |
HCV – Hepatitis C virus; SLE – Systemic lupus erythematosus; KSA – Kingdom of Saudi Arabia